recombin antibody highly specify detect probe research diagnose emerge last two dead fastest grow class therapeutic protein antibody genre drama accuser vitro select system particularly phage display increase variety product develop rang grained post bacteria yeast filament fungi insect cell line mammalian cell transfer plant anim current almost still product order reduce risk immunogen due alter inhuman glycol pattern howe recent develop glycosylationengin yeast promise obtain humanoid posttransl modify furthermore smaller fragment include bispecif without success advance clinic test first product nonmammalian source expect come next year review focus current usable differ applied 